A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/343 (2006.01) A61K 9/70 (2006.01) A61K 31/33 (2006.01) A61K 31/4355 (2006.01) A61K 45/06 (2006.01) A61K 47/10 (2006.01) A61K 47/14 (2006.01) A61K 47/18 (2006.01) A61K 47/34 (2006.01) A61P 25/20 (2006.01) C07D 307/93 (2006.01)
Patent
CA 2381468
Percutaneous absorption agents which make it possible to absorb compounds having a melatonin receptor agonism via a convenient administration system, have favorable blood concentration passage characteristics and can exert a therapeutic effect on a disease caused by a decrease in melatonin at night.
Agents d'absorption percutanée permettant d'absorber des composés possédant un agonisme pour le récepteur de mélatonine par l'intermédiaire d'un système d'administration approprié. Ces agents d'absorption possèdent des caractéristiques avantageuses de passage de la concentration sanguine et peuvent exercer un effet thérapeutique sur une maladie provoquée par une diminution de la mélatonine la nuit.
Iga Katsumi
Miyamoto Masaomi
Suzuki Yasuyuki
Fetherstonhaugh & Co.
Takeda Chemical Industries Ltd.
Takeda Pharmaceutical Company Limited
LandOfFree
Percutaneous absorption preparations containing melatonin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Percutaneous absorption preparations containing melatonin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Percutaneous absorption preparations containing melatonin... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1411499